<b><div>RC 2018 - What is the function of BMP?</div><ol><li><div>Recruitment of mesenchymal stem cells</div></li><li><div>Differentiation of oseto progenitor to osteoblasts-like cells</div></li><li><div>Cell that survive implantation form bone</div></li><li><div>Promotes RANK to form bone</div></li></ol></b>
<b><div>B (maybe A)</div><div> </div><div>OKU 10</div><ul><li><div>Induces differentiation of mesenchymal stem cells to osteoprogenitor cells</div></li><li><div>Recruitment of mesenchymal stem cells</div></li><li><div>Stimulation of angiogenesis</div></li></ul></b>
RFs for Metal hypersensitivity? MCQ 2018
<b>female (not male): RR 4</b><div>piercings: 3.2</div><div>hand eczema: RR 3</div><div>smoking: RR 3</div>
MOA of BMP (MCQ 2018, SAQ 2010)
<div><b>Induces differentiation of mesenchymal stem cells to osteoprogenitor cells and osteoblasts (MCQ 2018)</b></div>
<div><div>Recruitment of mesenchymal stem cells</div> <div>Stimulation of angiogenesis</div></div>
peri-op mx of rheumatoid meds?
stop biologics 2 weeks before, start 2 weeks after (MCQ 2018)<div><br></br></div><div>continue MTX, plaquenil (hydroxy)</div>
HIV transmission?
0.3% HIV<div>3% Hep C</div><div>30% Hep B</div>
Complication with INFIX?
<b>LFCN palsy</b> - 0-30% (MCQ 2018)<div>HO 0-25%<br></br><div><br></br></div></div>
short vs long im nail for intertroch fracture?
short nail is cheaper<div><b>increased iatrogenic fractures in long (mcq 2018)</b></div><div>equal: torsional strength, risk of rotational abnormalities</div>
Properties of BG?
Osteogenic (OG): viable osteoblasts or stem cells (MSC) that can differentiate down bone forming lineage<div><br></br></div><div>Osteoconductive (OC): 3-D architecture (ie scaffold) that promotes bone formation</div><div><br></br></div><div>Osteoinductive (OI): BMPs to support cell proliferation or differentiation<br></br></div>
Dx criteria for RA?
“<img></img>”
Agents to decrease intra-op bleeding
“<div> <div> <div><img></img></div> </div></div>”
<div>RC 2014 - Name 6 modifiable risk factors for osteoporosis, excluding medications</div>
“<ul> <li>Sedentary Lifestyle</li> <li>Smoking</li> <li>Alcohol Intake</li> <li>Low body weight</li> <li>Diet low in calcium/vitamin D</li> <li>Diet low in protein</li></ul><div>RFs in general - SocHx, FHx, PMHx, Meds</div><div>Couple things together!</div><div><ul> <li>Smokers - COPD</li> <li>EtoH - liver dz</li> <li>Steroids - RA, MTX</li> <li>Low BMI - low protein intake - malabsorption syndromes</li></ul></div><div><img></img><br></br></div>”
<div>RC 2012 - All of the following regarding transient osteoporosis is true except:</div>
<ol> <li>Happens mostly in middle aged men</li> <li>Half of cases are in the upper extremity</li> <li>It is associated with no significant loss of range of motion</li> <li>It is self-limiting</li></ol>
B.<div><ul> <li>TO affects mostly young and <b><u>middle-aged men</u></b> and, rarely, women during the last 3 months of pregnancy or immediate postpartum period</li> <li><b><u>Typically involves only the lower extremities,</u></b> especially the hip joint and, less frequently, the knee, ankle and foot</li> <li>Pain worse with weight bearing and associated with limping, then gradual subsidence in 4-9 months</li> <li>Minimal restriction of ROM and pain at extremes</li> <li>Cause unknown</li> <li>Labs usually non-contributory, but differentiate from other pathologies</li> <li>Demineralization on radiographs (delayed 3-6 weeks from onset)</li> <li>TO is a self-limited disease</li></ul></div>
<div>RC 2014 - All of the following are true, EXCEPT?</div>
<ol> <li>Both rickets and osteomalacia are due to deficient mineralization of osteoid</li> <li>Osteoporosis in Caucasian females is defined as a bone mineral density T-score 1.5 below the mean</li> <li>Estrogen preserves bone mineral density by decreasing the frequency of bone remodeling cycles</li> <li>Vertebral compression fractures are twice as common as hip fractures</li></ol>
B.<div><ul> <li>Rickets = osteomalacia</li> <ul> <li>Adefect inmineralizationof osteoid matrix caused by inadequate calcium and phosphate</li> <ul> <li>prior to closure of physis known asrickets</li> <li>after physeal closure calledosteomalacia</li> </ul> </ul> <li>Osteoporosis t < -2.5</li></ul></div>
RC 2018 - What is the function of BMP? <ol> <li>Recruitment of mesenchymal stem cells</li> <li>Differentiation of oseto progenitor to osteoblasts-like cells</li> <li>Cell that survive implantation form bone</li> <li>Promotes RANK to form bone</li></ol>
“B.<div><br></br></div><div><img></img><br></br></div>”
<div><b>RC 2011 - What are two mechanisms of action of BMP?</b></div>
<div>o<b><i>OKU 10</i></b><b></b></div>
<div>·<b>Induces differentiation of mesenchymal stem cells to osteoprogenitor cells</b></div>
<div>·<b>Recruitment of mesenchymal stem cells</b></div>
<div>·<b>Stimulation of angiogenesis</b></div>
<div><b>RC 2015 - 65yo female with history of bisphosphonate use presents with proximal femur fracture. List 5 X-RAY findings associated with bisphosphonate therapy. </b></div>
<div><b><i>JAAOS - Atypical Femur Fractures</i></b><b></b></div>
<ul><li>Lateral cortical beaking</li> <li>Generalized increase in cortical thickness of femoral diaphysis</li> <li>Transverse tension side fracture line</li> <li>Minimal fracture comminution</li> <li>Bilateral incomplete diaphyseal fractures</li> <li>Delayed fracture healing</li></ul>
RC 2013 - Which drug do you have to stop before TKA for a rheumatoid patient <ol> <li>Hydroxychloroquine</li> <li>Glucosamine and Chondroitan </li> <li>Prednisone</li> <li>Methotrexate</li></ol>
“B.<div><ul> <li>the 5 g’s of herbal medicines to stop before surgery: Gingko balboa, garlic, glucosamine, guava, ginseng. They increase bleeding time (PTT)</li> <li>Hydroxycholorquine: This is Not an immunosuppressant and may confer benefits for anti-embolism post-op. Therefore, it should be continued peri-operatively.</li> <li>Prednisone: There is an increased risk of infection if the patient is using over 5mg per day, and this risk increases with increasing duration of therapy. You cannot stop it peri-operatively though because the patient will have their endogenous steroid production chronically suppressed from their prednisone treatment. They therefore cannot mount a stress response to produce their own corticosteroid. The European league against rheumatism has recommended stress dose of 100mg hydrocortisone intraop</li> <li>Methotrexate: This is continued perioperatively as recommended by an international task force. There is slight increase in post op infection risk, but the infection risk is higher with corticosteroids</li> <li>Anti-tnf agents such as infliximab should be stopped – they increase infection risk. Can be restarted 2 weeks after surgery.</li></ul></div>”
<div>RC 2012 - What is the mechanism of action of Botox?</div>
<ol> <li>Inhibits ACTH release from presynaptic vesicles</li> <li>Inhibits calcium release from sarcoplasmic reticulum</li> <li>Blocks ACTH post-synaptic receptor</li> <li>GABA agonist</li></ol>
A.<div><ul> <li>JAAOS 2003 - Botulinum Neurotoxin Type A</li> <ul> <li>The final effect of the toxin is a reduction in the release of acetylcholine at the nerve terminal (PRE-SYNAPTIC)</li> </ul> </ul> <div></div></div>
RC 2008 -<b>What is a side effect of bisphosphonates</b> <div><b>a. </b><b>femoral head necrosis</b></div> <div><b>b. </b><b>mandible osteonecrosis</b></div> <div><b>c. </b><b>osteopenia</b></div> <div><b>d. </b><b>Hypocalcemia</b></div>
B. madible avn really only an adult phenomenon<div><br></br></div><div> <div>o However transient hypocalcemia is seen when starting bisphosphonates, hence why they are used in acute hypercalcemia crisis</div></div>
<div>RC 2014 - Regarding bisphosphonate use in the pediatric population, all are true EXCEPT?</div>
<ol> <li>Osteonecrosis of jaw</li> <li>Flu-like symptoms</li> <li>Limb pain</li> <li>May have delayed healing of osteotomies performed in osteogenesis imperfecta patients</li></ol>
<div><div>RC 2013 - What is not a side effect of bisphosphonate treatment in kids</div> <ol> <li>Acute fever with administration</li> <li>Growth delay</li> <li>Prolonged effects on bone remodelling</li> <li>Immediate and transient hypocalcemia</li></ol></div>
RC 2014 - A.<div><br></br></div><div>RC 2013 - B</div><div><br></br></div><div><div>Side effects of Bisphosphonates</div> <div>1. Acute phase reaction: fevers, malaise, diarrhea, bone and muscle pain. Occur 1-3 days after administration.</div> <div>2. Transient Electrolyte abnormalities: hypocalcemia, hypophosphatemia, hypomagnesemia. These are mild and assymptomatic and resolve within a couple of days. Prevention can be done with Ca and Vit D supplementation</div> <div>3. Uveitis</div> <div>4. Thrombocytopenia</div> <div>5. Oral ulceration</div> <div>6. AVN of the jaw - only reported in adults, not in children (RC EXAM)</div> <div>7. Exacerbation of reactive airway disease (like asthma)</div> <div>8. Cross the placenta so may affect the fetus (not reported)</div> <div>9. Has NOT been shown to delay healing of fractures in kids, but may delay healing of osteotomies </div> <div>10. Suppressed bone turnover markers for up to 2 years after treatment.</div></div>
<div>RC 2016 - Mechanism of function of biologics in RA:</div>
<ol> <li>TNF agonist</li> <li>TNF antagonist</li> <li>IL-2 antagonist</li> <li>IL-2 agonist</li></ol>
“2.<div><br></br></div><div><div> <div> <div><img></img></div> </div></div></div>”
<div>RC 2016 - Fight bite. What antibiotic? </div>
<ol> <li>Keflex </li> <li>Amox-Clav </li> <li>TMP/SMX </li> <li>?</li></ol>
“b.<div><ul> <li>JAAOS 2015 - Human and Other Mammalian Bite Injuries of the Hand</li> <ul> <li>Common Bacteria Isolated from Infected Bite Wounds:</li> <ul> <li>Aerobic - Step, Staph, Eikenella, Haemophilus, Enterobacteriacae, Gernella, Neisseria</li> <li>Anaerobic - Prevotella, Fusobacterum, Eubacterium, Veillonella, Peptostreoptococcus</li> </ul> </ul> </ul> <div><img></img></div><div><br></br></div><div><br></br></div></div>”
<div>RC 2008 - Vancomycin. All are true EXCEPT</div>
<ol> <li>Cleared by glomerular filtration</li> <li>Red man syndrome can be prevented by slow administration</li> <li>Measuring peaks is more useful than measuring troughs in determining effective dosing</li> <li>Inhibits cell wall formation</li></ol>
<div>C.</div>
<ul> <li>See AAOS Review – Vancomycin acts by Bactericidal Inhibition of cell wall synthesis. Disrupts peptioglycan cross-linkageDOC for MRSA. Red man syndrome (5% to 13% of patients), side effects are nephrotoxicity/ototoxicity, neutropenia, thrombocytopenia.</li> <li>Vancomycin, JAAOS, 2005 - is nephrotoxic and ototoxic, monitor serum levels, inhitibs cell wall synthesis, poor GI absorption, better IV, glomerular filtration is the primary clearance, hepatic metabolism is minor, half life is 6 hours, adverse effects include infusion related erythema, pruritis, phlebitis and Red Man Syndrome (involves a pruritic, erythematous rash on the upper trunk, neck, and face associated with rapid vancomycin infusion causing histamine release), Vancomycin should be infused at a rate of 1,000 mg over 60 minutes, with larger doses taking proportionately longer to infuse, red man syndrome can be ameliorated with a slower rate of infusion and antihistamine premedication, trough serum concentrations of 5 to 10 μg/mL and peak serum concentrations of 20 to 40 μg/mL typically are desired, <b>in determining treatment outcome, evidence for monitoring trough concentrations is stronger than for monitoring peak concentrations</b></li></ul>
RC 2009 - In your hospital, among patients with a post-op wound infection, 35% of them have MRSA. What do you use for pre-op prophylaxis? <ol> <li>Cefazolin</li> <li>Vanco</li> <li>Clinda</li> <li>Gentamicin</li></ol>
“A.<div><ul> <li>2013 ASHP Clinical practice guidelines for anti-microbial prophylaxis in surgery</li> <ul> <li>"”Routine use of vancomycin prophylaxis is not recommended for any procedure. Vancomycin may be included in the regimen of choice when a cluster of MRSA cases have been detected at an institution. Vancomycin prophylaxis should be considered in patients with known MRSA colonization or at high risk for MRSA colonization in the absence of surveillance data””</li> <li><b>"”Although vancomycin is commonly used when the risk of MRSA is high, data suggest that vancomycin is less effective than cefazolin for preventing SSIs caused by MSSA.””</b></li> </ul></ul></div>”